Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Tomonori Fujishima"'
Autor:
Takao Kawabe, Shuntaro Obi, Haruhiko Yoshida, Shinpei Sato, Takashi Ishikawa, Takuma Teratani, Shuichiro Shiina, Tomonori Fujishima, Masao Omata, Yukihiro Koike, Ryosuke Tateishi
Publikováno v:
Gastroenterology. 129:122-130
Percutaneous radiofrequency ablation is a recently introduced treatment for hepatocellular carcinoma, whereas ethanol injection is now a standard therapy. We compared their long-term outcomes.Two hundred thirty-two patients with hepatocellular carcin
Autor:
Tomonori Fujishima, Shuntaro Obi, Masao Omata, Yukihiro Koike, Takuma Teratani, Hiroshi Imamura, Ryosuke Tateishi, Haruhiko Yoshida, Masatoshi Makuuchi, Shinpei Sato, Shuichiro Shiina, Kiyoshi Hasegawa
Publikováno v:
Gut. 54:419-425
Background: The prognosis of hepatocellular carcinoma (HCC) is highly dependent on tumour extension and liver function. Recently, two new prognostic scoring systems—the CLIP score, developed by Italian investigators and the BCLC score, developed in
Autor:
Takashi Ishikawa, Shuichiro Shiina, Ryosuke Tateishi, Haruhiko Yoshida, Masatoshi Imamura, Tomonori Fujishima, Takuma Teratani, Yukihiro Koike, Keisuke Hamamura, Masatoshi Akamatsu, Shinpei Sato, Masao Omata, Shuntaro Obi
Publikováno v:
Liver International. 24:625-629
Background: Transcatheter arterial embolization (TAE) may reduce the risk of hepatocellular carcinoma (HCC) recurrence when performed before percutaneous tumor ablation (PTA), either percutaneous ethanol injection therapy (PEIT) or radiofrequency abl
Autor:
Masao Omata, Takashi Ishikawa, Yasushi Shiratori, Takuma Teratani, Tomonori Fujishima, Ryosuke Tateishi, Haruhiko Yoshida, Shuichiro Shiina, Shinpei Sato, Shuntaro Obi, Yukihiro Koike, Masatoshi Akamatsu
Publikováno v:
European Journal of Gastroenterology & Hepatology. 16:459-466
Objective Hepatitis C virus (HCV) genotype and virus load, the strongest determinants of the efficacy of interferon therapy, have been presumed to be associated with risk for hepatocellular carcinoma (HCC). This study was conducted to elucidate wheth
Autor:
Ryosuke Tateishi, Yasuo Imai, Keisuke Hamamura, Yasushi Shiratori, Takashi Ishikawa, Shuntaro Obi, Masao Omata, Yasuo Tanaka, Takuma Teratani, Yukihiro Koike, Shuichiro Shiina, Masamichi Kojiro, Miho Kanda, Masatoshi Akamatsu, Masaki Takayanagi, Tomonori Fujishima
Publikováno v:
Journal of Gastroenterology. 38:288-294
Congenital absence of the portal vein is an extremely rare anomaly, in which enteric blood bypasses the liver and drains into the inferior vena cava. A 16-year-old girl was referred to our hospital presenting with liver tumor. Although she had suffer
Publikováno v:
IEEJ Transactions on Fundamentals and Materials. 114:123-128
Autor:
Tomonori, Fujishima, Takashi, Ishikawa, Yasushi, Shiratori, Miho, Kanda, Ryosuke, Tateishi, Masatoshi, Akamatsu, Yukihiro, Koike, Shinpei, Sato, Shuntaro, Obi, Keisuke, Hamamura, Takuma, Teratani, Shuichiro, Shiina, Haruhiko, Yoshida, Takao, Kawabe, Masao, Omata
Publikováno v:
Hepato-gastroenterology. 53(72)
It is not known whether the putative etiologic factors and clinical and pathological features of hepatocellular carcinoma differ between young adults and older patients. Therefore this study aims to evaluate whether the clinicopathological features i
Autor:
Masatoshi, Akamatsu, Takashi, Ishikawa, Yasushi, Shiratori, Yukihiro, Koike, Shuichiro, Shiina, Takuma, Teratani, Keisuke, Hamamura, Shuntro, Obi, Shinpei, Sato, Ryousuke, Tateishi, Tomonori, Fujishima, Yasuo, Imai, Haruhiko, Yoshida, Masao, Omata
Publikováno v:
Hepato-gastroenterology. 52(62)
We investigated the clinical factors predisposing moderately or poorly differentiated hepatocellular carcinoma and analyzed which clinical and histological factors are associated with poorly differentiated hepatocellular carcinoma (HCC) recurrence.Pe
Autor:
Ryosuke Tateishi, Shuichiro Shiina, Takuma Teratani, Masao Omata, Takao Kawabe, Shuntaro Obi, Haruhiko Yoshida, Tomonori Fujishima, Shinpei Sato, Yukihiro Koike
Publikováno v:
Cancer. 103(6)
BACKGROUND Radiofrequency ablation (RFA) was introduced recently as a therapeutic modality for hepatocellular carcinoma (HCC), an alternative to percutaneous ethanol injection therapy (PEIT), which is coming into use worldwide. Previously reported tr
Autor:
Takuma, Teratani, Haruhiko, Yoshida, Yoshida, Haruhiko, Shuichiro, Shiina, Shiina, Shuichiro, Shuntaro, Obi, Obi, Shuntaro, Shinpei, Sato, Sato, Shinpei, Yukihiro, Koike, Koike, Yukihiro, Keisuke, Hamamura, Hamamura, Keisuke, Masatoshi, Akamatsu, Akamatsu, Masatoshi, Tomonori, Fujishima, Fujishima, Tomonori, Yasuo, Imai, Imai, Yasuo, Takao, Kawabe, Kawabe, Takao, Yasushi, Shiratori, Shiratori, Yasushi, Masao, Omata, Omata, Masao
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver. 24(6)
Purpose: To evaluate the usefulness of the alternate display of arterial and equilibrium phase images (ADAEI) of 2 mm-pitch reconstruction computed tomography (CT) in the detection of hepatocellular carcinoma (HCC). Materials and methods: One hundred